1.Stricof, RL, Morse, DL, HTLVIII/LAV seroconversion following a deep intramuscular needlestick injury. N Engl J Med 1986;314:115.
2.Wormser, GRJoline, C, Duncanson, F. Needle-stick injuries during the care of patients with AIDS. N Engl J Med 1984;310:1461–1462.
3.Centers for Disease Control. Prospective evaluation of health-care workers exposed via parenteral or mucous-membrane routes to blood and body fluids of patients with acquired immunodeficiency syndrome. MMWR 1984;33:181–182.
4.Marcus, R, the CDC Cooperative Needlestick Surveillance Group. Surveillance of health care workers exposed to blood from patients infected with the human immunodeficiency virus. N Engl J Med 1988;319:1118–1123.
5.Henderson, DK, Saah, AJ, Zak, BJ, et al. Risk of nosocomial infection with human T-cell lymphotropic virus type III/lymphadenopathy-associated virus in a large cohort of intensively exposed health care workers. Ann Intern Med 1986;104:644–647.
6.Gerberding, JL, Bryant-LeBlanc, CE, Nelson, K, et al. Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditions. J Infect Dis 1987;156:1–8.
7.Klein, RS, Phelan, JA, Freeman, K, et al. Low occupational risk of human immunodeficiency virus infection among dental professionals. N Engl J Med 1988;318:86–90.
8.Chirgwin, K, Rao, TKS, Landesman, SH. HIV infection in a high prevalence dialysis unit. AIDS 1989;3:731–735.
9.Cowan, DN, Bundage, JF, Pomerantz, RS, Miller, RN, Burke, DS. HIV infection among members of the US Army Reserve Components with medical and health occupations. JAMA 1991;265:2826–2830.
10.Tokars, JI, Chamberland, ME, Schable, CA, et al. A survey of occupational blood contact and HIV infection among orthopedic surgeons. JAMA 1992;268:489–494.
11.Lifson, AR, Castro, KG, McCray, E, Jaffe, HW. National surveillance of AIDS in health care workers. JAMA 1986;256:3231–3234.
12.Centers for Disease Control. Surveillance for occupationally acquired HIV infection: United States, 1981-1992. MMWR 1992;41:823–825.
13.Centers for Disease Control. Recommendations for prevention of HIV transmission in health-care settings. MMWR 1987;36(suppl 2S):3S–18S.
14.Centers for Disease Control. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health care settings. MMWR 1988;37:377-382, 387–388.
15.Centers for Disease Control and Prevention. Alert: Preventing Needlestick Injuries in Health Care Settings. Atlanta, GA: U.S. Department of Health and Human Services, National Institute for Occupational Safety and Health; 1999. Publication no. 2000-108.
16.Centers for Disease Control and Prevention. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR 2001;50(RR 1):1–42.
17.Beekman, SE, Vlahov, DT, Koziol, DE, Shalley, ED, Schmitt, JM, Henderson, DK. Temporal association between implementation of universal precautions and a sustained, progressive decrease in percutaneous exposures to blood. Clin Infect Dis 1994;18:562–569.
18.Fahey, BJ, Koziol, DE, Banks, SM, Henderson, DK. Frequency of nonparenteral occupational exposures to blood and body fluids before and after universal precautions training. Am J Med 1991;90:145–153.
19.Mendelson, MH, Short, LJ, Schechter, CB, et al. Study of a needleless intermittent intravenous-access system for peripheral infusions: analysis of staff, patient, and institutional outcomes. Infect Control Hosp Epidemiol 1998;19:401–406.
20.Centers for Disease Control and Prevention. Evaluation of safety devices for preventing percutaneous injuries among health-care workers during phlebotomy procedures: Minneapolis-St. Paul, New York City, and San Francisco, 1993-1995. MMWR 1997;46:21–25.
21.Jagger, J. Reducing occupational exposure to bloodborne pathogens: where do we stand a decade later? Infect Control Hosp Epidemiol 1996;17:573–575.
22.Cardo, DM, Culver, DH, Ciesielski, CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. N Engl J Med 1997;337:1485–1490.
23.Ippolito, G, Puro, V, Heptonstall, J, Jagger, J, De Carli, G, Petrosillo, N. Occupational human immunodeficiency virus in health care workers: worldwide cases through September 1997. Clin Infect Dis 1999;28:365–383.
24.Centers for Disease Control and Prevention. U.S. HIV and AIDS cases reported through June 2001. HIV/AIDS Surveillance Report 2002;13:1–41.
25.Centers for Disease Control and Prevention. Surveillance of health care workers with HIV/AIDS. Atlanta, GA: Centers for Disease Control and Prevention. Available at www.cdc.gov/hiv/pubs/facts/hcwsurv.htm. Accessed August 6, 2002.
26.Centers for Disease Control. A cluster of Kaposi's sarcoma and Pneumocystis carinii pneumonia among homosexual male residents of Los Angeles and Orange Counties, California. MMWR 1982;31:305–307.
27.Centers for Disease Control and Prevention. CDC guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. MMWR 1999;48(RR-13):1–31.
28.Ou, CY, Kwok, S, Mitchell, SW, et al. DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science 1988;239:295–297.
29.Reitz, MS, Hall, L, Robert-Guroff, M, et al. Viral variability and serum antibody response in a laboratory worker infected with HIV Type 1 (HTLV Type mS). AIDS Res Hum Retroviruses 1994;10:1143–1155.
30.Centers for Disease Control. Update: human immunodeficiency virus infections in health-care workers exposed to blood of infected patients. MMWR 1987;36:285–289.
31.Ridzon, R, Gallagher, K, Ciesielski, C, et al. Simultaneous transmission of both human immunodeficiency virus and hepatitis C virus from a needlestick injury. N Engl J Med 1997;336:919–922.
32.Beltrami, EM, Kozak, A, Williams, IT, et al. Transmission of HIV and hepatitis C virus from a nursing home patient to a health care worker. Am J Infect Control. In press.
33.Tokars, JI, Marcus, R, Culver, DH, et al. Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. Ann Intern Med 1993;118:913–919.
34.Pratt, RD, Shapiro, JF, McKinney, N, Kwok, S, Spector, S. Virologie characterization of primary human immunodeficiency virus type 1 infection in a health care worker following needlestick injury. J Infect Dis 1995;172:851–854.
35.Jochimsen, EM. Failures of zidovudine postexposure prophylaxis. Am J Med 1997;102(5B):52–55.
36.Beltrami, EM, Luo, C-C, Dela Torre, N, Cardo, DM. Transmission of drug-resistant HIV after an occupational exposure despite postexposure prophylaxis with a combination drug regimen. Infect Control Hosp Epidemiol 2002;23:345–348.
37.Henry, K, Erice, A, Tierney, C, et al. A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS: AIDS Clinical Trial Group 193A Study Team. J Acquir Immune Defic Syndr Hum Retrovirol 1998;19:339–349.
38.McNaghten, AD, Hanson, DL, Jones, JL, Ward, JW, Dworkin, MS. Effects of antiretroviral therapy and opportunistic illness primary chemopro-phylaxis on survival after AIDS diagnosis: Adult/Adolescent Spectrum of Disease Group. AIDS 1999;13:1687–1695.
39.Palella, FJ Jr, Delaney, KM, Moorman, AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection: HIV Outpatient Study investigators. N Engl J Med 1998; 338:853–860.
41.Sperling, RS, Shapiro, DE, Coombs, RW, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med 1996;335: 1621–1629.
42.Cao, Y, Krogstad, P, Korber, BT, et al. Maternal HIV-1 viral load and vertical transmission of infection: the Ariel Project for the prevention of HIV transmission from mother to infant. Nat Med 1997;3:549–552.
43.Chiarello, LA, Gerberding, JL. Human immunodeficiency virus in health care settings. In: Mandeli, GL, Bennett, JE, Dolin, R, eds. Principles and Practice of Infectious Diseases, 5th ed. Philadelphia: Churchill Livingstone; 2000:3052–3054.
44.Ho, DD, Moudgil, T, Alam, M. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 1989; 321:1621–1625.
45.Chamberland, ME, Ciesielski, CA, Howard, RJ, Fry, DE, Bell, DM. Occupational risk of infection with human immunodeficiency virus. Surg Clin North Am 1995;75:1057–1070.
46.Jagger, J. Introducing A.E.P: a new opportunity to make the health care workplace safer. Advances in Exposure Prevention 1994;1:2.
47.Cardo, D, Marcus, R, McKibben, P, Culver, D, Bell, D, the Cooperative Needlestick Study Group. Preventability of hollowbore needle exposures among health-care workers (HCWs). Infect Control Hosp Epidemiol 1994;15:20. Abstract.
48.Haiduven, DJ, DeMaio, TM, Stevens, DA, A five year study of needlestick injuries: significant reduction associated with communication, education, and convenient placement of sharps containers. Infect Control Hosp Epidemiol 1992;13:265–271.
49.Linnemann, CC, Cannon, C, DeRonde, M, Lanphear, B. Effect of educational programs, rigid sharps containers, and universal precautions on reported needlestick injuries in healthcare workers. Infect Control Hosp Epidemiol 1991;12:214–219.
50.Weltman, AC, Short, LJ, Mendelson, MH, Lilienfeld, DE, Rodriguez, M. Disposal related sharps injuries at a New York City teaching hospital. Infect Control Hosp Epidemiol 1995;16:268–274.
51. Pub L No. 106430, Needlestick Safety and Prevention Act. (November 6, 2000).
52.Zafar, AB, Butler, RC, Podgorny, JM, Mennonna, PA, Gaydos, LA, Sandiford, JA. Effect of a comprehensive program to reduce needlestick injuries. Infect Control Hosp Epidemiol 1997;18:712–715.
53.Dilley, JW, Woods, WJ, McFarland, W. Are advances in treatment changing views about high-risk sex? N Engl J Med 1997;337:501–502.
54.Kelly, JA, Hoffman, RG, Rompa, D, Gray, M. Protease inhibitor combination therapies and perceptions of gay men regarding AIDS severity and the need to maintain safer sex. AIDS 1998;12:F91–F95.
55.Katz, MH, Gerberding, JL. Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection drug use. N Engl J Med 1997;336:1097–1100.
56.Lehman, JS, Hecht, FM, Wortley, P, Lansky, A, Stevens, M, Fleming, P. Are at-risk populations less concerned about HIV infection in the HAART era? Presented at the 7th Annual Conference on Retroviruses and Opportunistic Infections; January 30-February 2, 2000; San Francisco, CA. Abstract 198.
57.Wang, SA, Panlilio, AL, Doi, PA, et al. Experience of healthcare workers taking postexposure prophylaxis after occupational HIV exposures: findings of the HIV Postexposure Prophylaxis Registry. Infect Control Hosp Epidemiol 2000;21:780–785.
58.Henry, K, Acosta, EP, Jochimsen, E. Hepatotoxicity and rash associated with zidovudine and zalcitabine chemoprophylaxis. Ann Intern Med 1996;124:855.
59.Hirsch, MS, Brun-Vezinet, F, D'Aquila, RT, et al. Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an international AIDS society-USA panel. JAMA 2000;282:2442–2444.
60.Short, L, Robert, L, Chamberland, M, et al. Underreporting of needlestick injuries (NSIs) among healthcare workers (HCWs). Infect Control Hosp Epidemiol 1994;15:20.
61.Jagger, J. Interview: Patricia Wetzel, M.D. Advances in Exposure Prevention 1994;3:10–11.
62.Beekman, SE, Fahey, BJ, Gerberding, JL, Henderson, DK. Risky business: using necessarily imprecise casualty counts to estimate occupational risks for HIV-1 infection. Infect Control Hosp Epidemiol 1990;11:371–379.
63.U.S. Department of Labor. Employment and Earnings. Washington, DC: Bureau of Labor Statistics; 2001. Available at www.bls.gov/cps/home.htm. Accessed July 26, 2002.
64.Department of Labor, Occupational Safety and Health Administration. Occupational exposure to bloodborne pathogens; needlestick and other sharps injuries: final rule. Federal Register 2001;66:5318–5325.
65.Centers for Disease Control and Prevention. Proposed projects. Federal Register 2000;65:49809–49810.